|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/395 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2178916 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08796917.6 |
| Europos patento paraiškos padavimo data | 2008-07-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-04-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-12-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/071709 |
| Data | 2008-07-31 |
| (87) | Numeris | WO 2009/018411 |
| Data | 2009-02-05 |
| (30) | Numeris | Data | Šalis |
| 962811 P | 2007-07-31 | US | |
| 67994 P | 2008-03-03 | US |
| (72) |
MARTIN, Joel, H., US
WANG, Li-Hsien, US
STEVENS, Sean, US
ALLISON, Erin, M., US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (54) | HUMAN ANTIBODIES TO HUMAN CD20 AND METHOD OF USING THEREOF |
| HUMAN ANTIBODIES TO HUMAN CD20 AND METHOD OF USING THEREOF |